Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Weighted Average) (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $57.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1.07% to $57.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.5 million through Dec 2025, up 1.07% year-over-year, with the annual reading at $57.5 million for FY2025, 1.07% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $57.5 million in Q4 2025 for Harmony Biosciences Holdings, roughly flat from $57.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $59.9 million in Q3 2023 to a low of $56.8 million in Q1 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $58.1 million across 5 years, with a median of $57.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 630.25% in 2021 and later decreased 5.12% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $57.5 million in 2021, then rose by 2.85% to $59.2 million in 2022, then increased by 0.5% to $59.5 million in 2023, then dropped by 4.35% to $56.9 million in 2024, then rose by 1.07% to $57.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for HRMY at $57.5 million in Q4 2025, $57.6 million in Q3 2025, and $57.4 million in Q2 2025.